It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1986.
1986 | Mumbai, Maharashtra, India | ActiveMarvel Drugs Pvt Ltd, a active private limited company, was established on 19 May 1986 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230MH1986PTC039868. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Employing 34 professional, Its leadership includes Nikhil Jitendra Shah (Managing Director), Abhishek Nikhil Shah (Director). Past directors included Jitendra Manilal Shah. It holds ₹1.27 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 20, Nagin Mahal, 5Th Floor, 82, Veer Nariman Road, Churchgate, Mumbai, Maharashtra, 400020.
U24230MH1986PTC039868
039868
19 May 1986
₹5.00 M
₹5.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Marvel Drugs Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhil Jitendra Shah | Managing Director | 21 Sep 1987 | Current |
| Abhishek Nikhil Shah | Director | 19 Dec 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Aug 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Marvel Drugs Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 22.14% decrease. The company also saw a substantial fall in profitability, with a 58.61% decrease in profit. The company's net worth moved up by a moderate rise of 8.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Marvel Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Apr 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹2.90 M | Open |
| 24 Jan 2017 | The Hongkong And Shanghai Banking Corporation Limited | ₹0.20 M | Open |
| 09 Mar 2016 | The Hongkong And Shanghai Banking Corporation Limited | ₹0.20 M | Open |
| 17 Jul 1987 | Bank Of India | ₹1.20 M | Open |
| 11 Dec 1986 | Bank Of India | ₹7.00 M | Open |
Explore comprehensive loan charge details -
Marvel Drugs has a workforce of 34 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Marvel Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marvel Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Marvel Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Marvel Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 2.90 M with Charge ID 100570663 was registered on 19 Apr 2022. was documented.
The activity A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 0.20 M with Charge ID 100077774 was registered on 24 Jan 2017. was completed.
Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 0.20 M with Charge ID 10628027 was registered on 09 Mar 2016. was documented.
Abhishek Nikhil Shah was appointed as a Director was appointed as a Director on 19 Dec 2002 & has been associated with this company since 22 years 11 months . was recorded as a recent event.
The CIN of Marvel Drugs Pvt Ltd is U24230MH1986PTC039868.
Marvel Drugs Pvt Ltd is headquartered at 20, Nagin Mahal, 5Th Floor, 82, Veer Nariman Road, Churchgate, Mumbai, Maharashtra, 400020.
Marvel Drugs Pvt Ltd was incorporated on 19 May 1986.
The current directors of Marvel Drugs Pvt Ltd are
The primary industry of Marvel Drugs Pvt Ltd is Manufacturing.
Marvel Drugs Pvt Ltd is unlisted.
The authorized capital of Marvel Drugs Pvt Ltd is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Marvel Drugs Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX